Desensitization of platelets to iloprost. Loss of specific binding sites and heterologous desensitization of adenylate cyclase

This publication has 41 references indexed in Scilit:

• Prostacyclin analogues reduce ADP‐ribosylation of the α‐subunit of the regulatory G_s‐protein and diminish adenosine (A₂) responsiveness of platelets
  British Journal of Pharmacology, 1987
• Dual regulation of adenylate cyclase. A signal transduction mechanism of membrane receptors
  Basic Research in Cardiology, 1986
• Desensitization of prostacyclin responsiveness in a neuronal hybrid cell line: selective loss of high affinity receptors
  British Journal of Pharmacology, 1985
• The use of a prostacyclin analogue, [3H]iloprost, for studying prostacyclin-binding sites on human platelets and neuronal hybrid cells
  Bioscience Reports, 1984
• Guanine nucleotide-binding regulatory proteins and dual control of adenylate cyclase.
  Journal of Clinical Investigation, 1984
• The cytoplasmic concentration of free calcium in platelets is controlled by stimulators of cyclic AMP production (PGD2, PGE1, forskolin)
  Biochemical and Biophysical Research Communications, 1983
• Phosphatidylinositol-specific phospholipase-C of platelets: Association with 1,2-diacylglycerol-kinase and inhibition by cyclic-AMP
  Biochemical and Biophysical Research Communications, 1979
• Cyclic adenosine 3′,5′-monophosphate and prostacyclin inhibit membrane phospholipase activity in platelets
  Biochemical and Biophysical Research Communications, 1977
• Modulation of human platelet adenylate cyclase by prostacyclin (PGX)
  Prostaglandins, 1977
• Activation and dissociation of adenosine 3′,5′-monophosphate-dependent and guanosine 3′,5′-monophosphate-dependent protein kinases by various cyclic nucleotide analogs
  Biochemical Pharmacology, 1974